Global Bio-pharma Market Insights, Forecast to 2025

Date: Feb 19 2019
|
QYRESEARCH
|
Number of Pages: 118
|
Alternate Text Alternate Text Alternate Text Alternate Text

The global Bio-pharma market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Bio-pharma market based on company, product type, end user and key regions.

This report studies the global market size of Bio-pharma in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Bio-pharma in these regions.
This research report categorizes the global Bio-pharma market by top players/brands, region, type and end user. This report also studies the global Bio-pharma market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
F. Hoffmann-La Roche AG
Johnson & Johnson Services
Sanofi, Amgen
AbbVie
Merck & Co., Inc
Biogen Idec
Bayer AG
Eli Lilly and Company
Novartis AG GlaxoSmithKline Plc
Bristol-Myers Squibb Company
AstraZeneca PLC
Abbott Laboratories

Market size by Product
Monoclonal Antibodies
Recombinant Proteins
Granulocyte-Colony Stimulating Factor (G-CSF)
Interferons
Recombinant Human Insulin
Erythropoietin
Vaccines
Growth Hormones
Purified Proteins
Others
Market size by End User
Metabolic Disorders
Oncology
Neurological Disorders
Cardiovascular Diseases
Inflammatory and Infectious Diseases
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Bio-pharma market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Bio-pharma market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Bio-pharma companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Bio-pharma submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Bio-pharma are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Bio-pharma market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents
1 Study Coverage
    1.1 Bio-pharma Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
           1.4.1 Global Bio-pharma Market Size Growth Rate by Product
           1.4.2 Monoclonal Antibodies
           1.4.3 Recombinant Proteins
           1.4.4 Granulocyte-Colony Stimulating Factor (G-CSF)
           1.4.5 Interferons
           1.4.6 Recombinant Human Insulin
           1.4.7 Erythropoietin
           1.4.8 Vaccines
           1.4.9 Growth Hormones
           1.4.10 Purified Proteins
           1.4.11 Others
    1.5 Market by End User
           1.5.1 Global Bio-pharma Market Size Growth Rate by End User
           1.5.2 Metabolic Disorders
           1.5.3 Oncology
           1.5.4 Neurological Disorders
           1.5.5 Cardiovascular Diseases
           1.5.6 Inflammatory and Infectious Diseases
           1.5.7 Others
    1.6 Study Objectives
    1.7 Years Considered
2 Executive Summary
    2.1 Global Bio-pharma Market Size
           2.1.1 Global Bio-pharma Revenue 2014-2025
           2.1.2 Global Bio-pharma Sales 2014-2025
    2.2 Bio-pharma Growth Rate by Regions
           2.2.1 Global Bio-pharma Sales by Regions
           2.2.2 Global Bio-pharma Revenue by Regions
3 Breakdown Data by Manufacturers
    3.1 Bio-pharma Sales by Manufacturers
           3.1.1 Bio-pharma Sales by Manufacturers
           3.1.2 Bio-pharma Sales Market Share by Manufacturers
           3.1.3 Global Bio-pharma Market Concentration Ratio (CR5 and HHI)
    3.2 Bio-pharma Revenue by Manufacturers
           3.2.1 Bio-pharma Revenue by Manufacturers (2014-2019)
           3.2.2 Bio-pharma Revenue Share by Manufacturers (2014-2019)
    3.3 Bio-pharma Price by Manufacturers
    3.4 Bio-pharma Manufacturing Base Distribution, Product Types
           3.4.1 Bio-pharma Manufacturers Manufacturing Base Distribution, Headquarters
           3.4.2 Manufacturers Bio-pharma Product Type
           3.4.3 Date of International Manufacturers Enter into Bio-pharma Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
    4.1 Global Bio-pharma Sales by Product
    4.2 Global Bio-pharma Revenue by Product
    4.3 Bio-pharma Price by Product
5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Bio-pharma Breakdown Data by End User
6 North America
    6.1 North America Bio-pharma by Countries
           6.1.1 North America Bio-pharma Sales by Countries
           6.1.2 North America Bio-pharma Revenue by Countries
           6.1.3 United States
           6.1.4 Canada
           6.1.5 Mexico
    6.2 North America Bio-pharma by Product
    6.3 North America Bio-pharma by End User
7 Europe
    7.1 Europe Bio-pharma by Countries
           7.1.1 Europe Bio-pharma Sales by Countries
           7.1.2 Europe Bio-pharma Revenue by Countries
           7.1.3 Germany
           7.1.4 France
           7.1.5 UK
           7.1.6 Italy
           7.1.7 Russia
    7.2 Europe Bio-pharma by Product
    7.3 Europe Bio-pharma by End User
8 Asia Pacific
    8.1 Asia Pacific Bio-pharma by Countries
           8.1.1 Asia Pacific Bio-pharma Sales by Countries
           8.1.2 Asia Pacific Bio-pharma Revenue by Countries
           8.1.3 China
           8.1.4 Japan
           8.1.5 Korea
           8.1.6 India
           8.1.7 Australia
           8.1.8 Indonesia
           8.1.9 Malaysia
           8.1.10 Philippines
           8.1.11 Thailand
           8.1.12 Vietnam
           8.1.13 Singapore
    8.2 Asia Pacific Bio-pharma by Product
    8.3 Asia Pacific Bio-pharma by End User
9 Central & South America
    9.1 Central & South America Bio-pharma by Countries
           9.1.1 Central & South America Bio-pharma Sales by Countries
           9.1.2 Central & South America Bio-pharma Revenue by Countries
           9.1.3 Brazil
    9.2 Central & South America Bio-pharma by Product
    9.3 Central & South America Bio-pharma by End User
10 Middle East and Africa
    10.1 Middle East and Africa Bio-pharma by Countries
           10.1.1 Middle East and Africa Bio-pharma Sales by Countries
           10.1.2 Middle East and Africa Bio-pharma Revenue by Countries
           10.1.3 GCC Countries
           10.1.4 Turkey
           10.1.5 Egypt
           10.1.6 South Africa
    10.2 Middle East and Africa Bio-pharma by Product
    10.3 Middle East and Africa Bio-pharma by End User
11 Company Profiles
    11.1 Pfizer
           11.1.1 Pfizer Company Details
           11.1.2 Company Business Overview
           11.1.3 Pfizer Bio-pharma Sales, Revenue and Gross Margin (2014-2019)
           11.1.4 Pfizer Bio-pharma Products Offered
           11.1.5 Pfizer Recent Development
    11.2 F. Hoffmann-La Roche AG
           11.2.1 F. Hoffmann-La Roche AG Company Details
           11.2.2 Company Business Overview
           11.2.3 F. Hoffmann-La Roche AG Bio-pharma Sales, Revenue and Gross Margin (2014-2019)
           11.2.4 F. Hoffmann-La Roche AG Bio-pharma Products Offered
           11.2.5 F. Hoffmann-La Roche AG Recent Development
    11.3 Johnson & Johnson Services
           11.3.1 Johnson & Johnson Services Company Details
           11.3.2 Company Business Overview
           11.3.3 Johnson & Johnson Services Bio-pharma Sales, Revenue and Gross Margin (2014-2019)
           11.3.4 Johnson & Johnson Services Bio-pharma Products Offered
           11.3.5 Johnson & Johnson Services Recent Development
    11.4 Sanofi, Amgen
           11.4.1 Sanofi, Amgen Company Details
           11.4.2 Company Business Overview
           11.4.3 Sanofi, Amgen Bio-pharma Sales, Revenue and Gross Margin (2014-2019)
           11.4.4 Sanofi, Amgen Bio-pharma Products Offered
           11.4.5 Sanofi, Amgen Recent Development
    11.5 AbbVie
           11.5.1 AbbVie Company Details
           11.5.2 Company Business Overview
           11.5.3 AbbVie Bio-pharma Sales, Revenue and Gross Margin (2014-2019)
           11.5.4 AbbVie Bio-pharma Products Offered
           11.5.5 AbbVie Recent Development
    11.6 Merck & Co., Inc
           11.6.1 Merck & Co., Inc Company Details
           11.6.2 Company Business Overview
           11.6.3 Merck & Co., Inc Bio-pharma Sales, Revenue and Gross Margin (2014-2019)
           11.6.4 Merck & Co., Inc Bio-pharma Products Offered
           11.6.5 Merck & Co., Inc Recent Development
    11.7 Biogen Idec
           11.7.1 Biogen Idec Company Details
           11.7.2 Company Business Overview
           11.7.3 Biogen Idec Bio-pharma Sales, Revenue and Gross Margin (2014-2019)
           11.7.4 Biogen Idec Bio-pharma Products Offered
           11.7.5 Biogen Idec Recent Development
    11.8 Bayer AG
           11.8.1 Bayer AG Company Details
           11.8.2 Company Business Overview
           11.8.3 Bayer AG Bio-pharma Sales, Revenue and Gross Margin (2014-2019)
           11.8.4 Bayer AG Bio-pharma Products Offered
           11.8.5 Bayer AG Recent Development
    11.9 Eli Lilly and Company
           11.9.1 Eli Lilly and Company Company Details
           11.9.2 Company Business Overview
           11.9.3 Eli Lilly and Company Bio-pharma Sales, Revenue and Gross Margin (2014-2019)
           11.9.4 Eli Lilly and Company Bio-pharma Products Offered
           11.9.5 Eli Lilly and Company Recent Development
    11.10 Novartis AG GlaxoSmithKline Plc
           11.10.1 Novartis AG GlaxoSmithKline Plc Company Details
           11.10.2 Company Business Overview
           11.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Sales, Revenue and Gross Margin (2014-2019)
           11.10.4 Novartis AG GlaxoSmithKline Plc Bio-pharma Products Offered
           11.10.5 Novartis AG GlaxoSmithKline Plc Recent Development
    11.11 Bristol-Myers Squibb Company
    11.12 AstraZeneca PLC
    11.13 Abbott Laboratories
12 Future Forecast
    12.1 Bio-pharma Market Forecast by Regions
           12.1.1 Global Bio-pharma Sales Forecast by Regions 2019-2025
           12.1.2 Global Bio-pharma Revenue Forecast by Regions 2019-2025
    12.2 Bio-pharma Market Forecast by Product
           12.2.1 Global Bio-pharma Sales Forecast by Product 2019-2025
           12.2.2 Global Bio-pharma Revenue Forecast by Product 2019-2025
    12.3 Bio-pharma Market Forecast by End User
    12.4 North America Bio-pharma Forecast
    12.5 Europe Bio-pharma Forecast
    12.6 Asia Pacific Bio-pharma Forecast
    12.7 Central & South America Bio-pharma Forecast
    12.8 Middle East and Africa Bio-pharma Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Bio-pharma Customers
    14.3 Sales Channels Analysis
           14.3.1 Sales Channels
           14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
    16.1 Research Methodology
           16.1.1 Methodology/Research Approach
           16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables and Figures
Figure Bio-pharma Product Picture
Table Bio-pharma Market Segments
Table Key Manufacturers Bio-pharma Covered
Table Global Bio-pharma Market Size Growth Rate by Product 2019-2025 (K Pcs) & (Million US$)
Figure Global Bio-pharma Sales Market Share by Product 2014-2025
Figure Monoclonal Antibodies Product Picture
Table Major Manufacturers of Monoclonal Antibodies
Figure Recombinant Proteins Product Picture
Table Major Manufacturers of Recombinant Proteins
Figure Granulocyte-Colony Stimulating Factor (G-CSF) Product Picture
Table Major Manufacturers of Granulocyte-Colony Stimulating Factor (G-CSF)
Figure Interferons Product Picture
Table Major Manufacturers of Interferons
Figure Recombinant Human Insulin Product Picture
Table Major Manufacturers of Recombinant Human Insulin
Figure Erythropoietin Product Picture
Table Major Manufacturers of Erythropoietin
Figure Vaccines Product Picture
Table Major Manufacturers of Vaccines
Figure Growth Hormones Product Picture
Table Major Manufacturers of Growth Hormones
Figure Purified Proteins Product Picture
Table Major Manufacturers of Purified Proteins
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Bio-pharma Market Size Growth Rate by End User 2019-2025 (K Pcs)
Figure Metabolic Disorders
Figure Oncology
Figure Neurological Disorders
Figure Cardiovascular Diseases
Figure Inflammatory and Infectious Diseases
Figure Others
Figure Bio-pharma Report Years Considered
Figure Global Bio-pharma Market Size 2014-2025 (Million US$)
Figure Global Bio-pharma Sales 2014-2025 (K Pcs)
Table Global Bio-pharma Market Size by Regions 2014-2019 (K Pcs) & (Million US$)
Table Global Bio-pharma Sales by Regions 2014-2019 (K Pcs)
Table Global Bio-pharma Sales Market Share by Regions 2014-2019
Figure Global Bio-pharma Sales Market Share by Regions 2014-2019
Figure 2018 Global Bio-pharma Sales Market Share by Regions
Table Global Bio-pharma Revenue by Regions 2014-2019 (Million US$)
Table Global Bio-pharma Revenue Market Share by Regions 2014-2019
Figure Global Bio-pharma Revenue Market Share by Regions 2014-2019
Figure 2018 Global Bio-pharma Revenue Market Share by Regions
Table Global Bio-pharma Sales by Manufacturers (2014-2019) (K Pcs)
Table Global Bio-pharma Sales Share by Manufacturers (2014-2019)
Figure Global Bio-pharma Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Bio-pharma Revenue by Manufacturers (2014-2019) (Million USD)
Table Bio-pharma Revenue Share by Manufacturers (2014-2019)
Figure Bio-pharma Value Share by Manufacturers in 2018
Table Key Manufacturers Bio-pharma Price (2014-2019) (USD/Pcs)
Table Bio-pharma Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Bio-pharma Product Type
Table Date of International Manufacturers Enter into Bio-pharma Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Bio-pharma Sales by Product (2014-2019) (K Pcs)
Table Global Bio-pharma Sales Share by Product (2014-2019)
Figure Global Bio-pharma Sales Market Share by Product (2014-2019)
Figure Global Bio-pharma Sales Market Share by Product in 2018
Table Global Bio-pharma Revenue by Product (2014-2019) (Million US$)
Table Global Bio-pharma Revenue Share by Product (2014-2019)
Figure Global Bio-pharma Revenue Market Share by Product (2014-2019)
Figure Global Bio-pharma Revenue Market Share by Product in 2018
Table Bio-pharma Price by Product 2014-2019 (USD/Pcs)
Table Global Bio-pharma Sales by End User (2014-2019) (K Pcs)
Table Global Bio-pharma Sales Share by End User (2014-2019)
Figure Global Sales Bio-pharma Market Share by End User (2014-2019)
Figure Global Sales Bio-pharma Market Share by End User in 2018
Figure North America Bio-pharma Sales Growth Rate 2014-2019 (K Pcs)
Figure North America Bio-pharma Revenue Growth Rate 2014-2019 (Million US$)
Table North America Bio-pharma Sales by Countries (2014-2019) (K Pcs)
Table North America Bio-pharma Sales Market Share by Countries (2014-2019)
Figure 2018 North America Bio-pharma Sales Market Share by Countries
Table North America Bio-pharma Revenue by Countries (2014-2019) (Million US$)
Table North America Bio-pharma Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Bio-pharma Revenue Market Share by Countries
Figure United States Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure United States Bio-pharma Revenue Growth Rate (2014-2019) (K Pcs)
Figure Canada Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure Canada Bio-pharma Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure Mexico Bio-pharma Revenue Growth Rate (2014-2019) (Million US$)
Table North America Bio-pharma Sales by Product (2014-2019) (K Pcs)
Table North America Bio-pharma Sales Market Share by Product (2014-2019)
Figure 2018 North America Bio-pharma Market Share by Product
Table North America Bio-pharma Sales by End User (2014-2019) (K Pcs)
Table North America Bio-pharma Sales Market Share by End User (2014-2019)
Figure 2018 North America Bio-pharma Market Share by End User
Figure Europe Bio-pharma Sales Growth Rate 2014-2019 (K Pcs)
Figure Europe Bio-pharma Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Bio-pharma Sales by Countries (2014-2019) (K Pcs)
Table Europe Bio-pharma Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Bio-pharma Sales Market Share by Countries
Table Europe Bio-pharma Revenue by Countries (2014-2019) (Million US$)
Table Europe Bio-pharma Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Bio-pharma Revenue Market Share by Countries
Figure Germany Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure Germany Bio-pharma Revenue Growth Rate (2014-2019) (Million US$)
Figure France Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure France Bio-pharma Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure UK Bio-pharma Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure Italy Bio-pharma Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure Russia Bio-pharma Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Bio-pharma Sales by Product (2014-2019) (K Pcs)
Table Europe Bio-pharma Sales Market Share by Product (2014-2019)
Figure 2018 Europe Bio-pharma Market Share by Product
Table Europe Bio-pharma Sales by End User (2014-2019) (K Pcs)
Table Europe Bio-pharma Sales Market Share by End User (2014-2019)
Figure 2018 Europe Bio-pharma Market Share by End User
Figure Asia Pacific Bio-pharma Sales Growth Rate 2014-2019 (K Pcs)
Figure Asia Pacific Bio-pharma Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Bio-pharma Sales by Countries (2014-2019) (K Pcs)
Table Asia Pacific Bio-pharma Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Bio-pharma Sales Market Share by Countries
Table Asia Pacific Bio-pharma Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Bio-pharma Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Bio-pharma Revenue Market Share by Countries
Figure China Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure China Bio-pharma Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure Japan Bio-pharma Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure Korea Bio-pharma Revenue Growth Rate (2014-2019) (Million US$)
Figure India Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure India Bio-pharma Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure Australia Bio-pharma Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure Indonesia Bio-pharma Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure Malaysia Bio-pharma Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure Philippines Bio-pharma Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure Thailand Bio-pharma Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure Vietnam Bio-pharma Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure Singapore Bio-pharma Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Bio-pharma Sales by Product (2014-2019) (K Pcs)
Table Asia Pacific Bio-pharma Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Bio-pharma Market Share by Product
Table Asia Pacific Bio-pharma Sales by End User (2014-2019) (K Pcs)
Table Asia Pacific Bio-pharma Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Bio-pharma Market Share by End User
Figure Central & South America Bio-pharma Sales Growth Rate 2014-2019 (K Pcs)
Figure Central & South America Bio-pharma Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Bio-pharma Sales by Countries (2014-2019) (K Pcs)
Table Central & South America Bio-pharma Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Bio-pharma Sales Market Share by Countries
Table Central & South America Bio-pharma Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Bio-pharma Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Bio-pharma Revenue Market Share by Countries
Figure Brazil Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure Brazil Bio-pharma Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure Argentina Bio-pharma Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Bio-pharma Sales by Product (2014-2019) (K Pcs)
Table Central & South America Bio-pharma Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Bio-pharma Market Share by Product
Table Central & South America Bio-pharma Sales by End User (2014-2019) (K Pcs)
Table Central & South America Bio-pharma Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Bio-pharma Market Share by End User
Figure Middle East and Africa Bio-pharma Sales Growth Rate 2014-2019 (K Pcs)
Figure Middle East and Africa Bio-pharma Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Bio-pharma Sales by Countries (2014-2019) (K Pcs)
Table Middle East and Africa Bio-pharma Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Bio-pharma Sales Market Share by Countries
Table Middle East and Africa Bio-pharma Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Bio-pharma Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Bio-pharma Revenue Market Share by Countries
Figure GCC Countries Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure GCC Countries Bio-pharma Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure Turkey Bio-pharma Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure Egypt Bio-pharma Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Bio-pharma Sales Growth Rate (2014-2019) (K Pcs)
Figure South Africa Bio-pharma Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Bio-pharma Sales by Product (2014-2019) (K Pcs)
Table Middle East and Africa Bio-pharma Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Bio-pharma Market Share by Product
Table Middle East and Africa Bio-pharma Sales by End User (2014-2019) (K Pcs)
Table Middle East and Africa Bio-pharma Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Bio-pharma Market Share by End User
Table Pfizer Company Details
Table Pfizer Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table F. Hoffmann-La Roche AG Company Details
Table F. Hoffmann-La Roche AG Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche AG Recent Development
Table Johnson & Johnson Services Company Details
Table Johnson & Johnson Services Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Johnson & Johnson Services Recent Development
Table Sanofi, Amgen Company Details
Table Sanofi, Amgen Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Sanofi, Amgen Recent Development
Table AbbVie Company Details
Table AbbVie Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table AbbVie Recent Development
Table Merck & Co., Inc Company Details
Table Merck & Co., Inc Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck & Co., Inc Recent Development
Table Biogen Idec Company Details
Table Biogen Idec Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Biogen Idec Recent Development
Table Bayer AG Company Details
Table Bayer AG Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bayer AG Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eli Lilly and Company Recent Development
Table Novartis AG GlaxoSmithKline Plc Company Details
Table Novartis AG GlaxoSmithKline Plc Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis AG GlaxoSmithKline Plc Recent Development
Table Bristol-Myers Squibb Company Company Details
Table AstraZeneca PLC Company Details
Table Abbott Laboratories Company Details
Table Global Bio-pharma Sales Forecast by Regions 2019-2025 (K Pcs)
Table Global Bio-pharma Sales Market Share Forecast by Regions 2019-2025
Table Global Bio-pharma Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Bio-pharma Revenue Market Share Forecast by Regions 2019-2025
Table Global Bio-pharma Sales Forecast by Product 2019-2025 (K Pcs)
Table Global Bio-pharma Sales Market Share Forecast by Product 2019-2025
Table Global Bio-pharma Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Bio-pharma Revenue Market Share Forecast by Product 2019-2025
Table Global Bio-pharma Sales Forecast by End User 2019-2025 (K Pcs)
Table Global Bio-pharma Sales Market Share Forecast by End User 2019-2025
Figure North America Bio-pharma Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure North America Bio-pharma Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Bio-pharma Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Europe Bio-pharma Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Bio-pharma Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Asia Pacific Bio-pharma Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Bio-pharma Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Central & South America Bio-pharma Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Bio-pharma Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Middle East and Africa Bio-pharma Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Bio-pharma Value Chain
Table Bio-pharma Customers List
Table Bio-pharma Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Electronic files(PDF) of market research reports will be dispatched within 12 to 24 hours. (Mon-Fri IST)

Select License Type

Need Help?
+
SUBSCRIBE TO THE MAILING TO KEEP UP WITH LATEST NEWS AND UPDATES
x
We use cookies to deliver the best possible experience on our website by improving the user experience, personalizing your visit, and compiling aggregate statistics. By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more visit our Privacy policy page.